Xenon Pharmaceuticals XENE Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's net income?
- Xenon Pharmaceuticals (XENE) reported net income of -$102.3M in Q1 2026.
- How has Xenon Pharmaceuticals's net income changed year-over-year?
- Xenon Pharmaceuticals's net income decreased by 57.3% year-over-year, from -$65.05M to -$102.3M.
- What is the long-term trend for Xenon Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's net income has grown at a 44.7% compound annual growth rate (CAGR), from -$78.88M to -$345.91M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.